AI in Fertility Treatment: Improving Outcomes

By Sumona Bose

January 6, 2024

Introduction

Artificial Intelligence (AI) has the potential to reconfigure the field of fertility treatment, according to a recent research article. The study explores how AI technologies can address the challenges associated with subjective assessments in clinical and embryological decision-making during infertility treatment.The research highlights the importance of developing and validating algorithms in a proper manner, including adhering to regulatory requirements and ensuring the availability of high-quality data. The consensus among a group of fertility experts is that AI algorithms, if properly developed, can standardize, automate, and improve in vitro fertilization (IVF) outcomes for the benefit of patients. However, collaboration between AI developers and healthcare professionals is crucial to make this a reality. This article will explore AI’s role in fertility treatment whilst improving outcomes.

AI’s benefits to Fertility Treatment

The advancements in computer power and the availability of data have led to the rise of predictive algorithms in various medical fields. While the concept of AI dates back to the early twentieth century, it was not until 2012 that machine learning (ML) gained widespread acceptance as a form of AI. A survey conducted among health professionals revealed that 72% of them are interested in implementing AI in their work, considering it as an extension rather than the extinction of professional capacity in healthcare.

In recent years, there has been a significant increase in the number of AI publications in medicine and health, making it one of the most promising fields of study in health science. The American Society for Reproductive Biology (ASRM) and the European Society for Human Reproduction and Embryology (ESHRE) have already reported on various applications of machine learning in fertility treatment. These applications range from sperm identification and morphology to predicting live births following embryo transfer.

Figure 1: Summary scheme of how AI can improve IVF treatments throughout the process

The potential benefits of AI in fertility treatment are vast. Data-driven solutions can help detect early indicators of infertility, allowing for earlier identification of potential patients and precise treatment strategies. AI can also assist in defining the best stimulation protocol for each patient and adjusting drugs and doses in real-time based on biomarkers. In the embryology and andrology laboratories, AI can evaluate gamete viability, embryo implantation potential, and uterine receptivity status, leading to improved pregnancy outcomes and reduced time to achieve a healthy live birth.

Conclusion

The researchers emphasize the need for continuous innovation in the fertility space to improve outcomes for patients. Objectivity must be brought into the decision-making process at every step of assisted reproductive technology (ART) to determine the most suitable treatment. The use of algorithms and AI can reduce subjectivity and improve consistency in critical areas of ART. AI’s role in fertility treatment is an important trajectory to explore further.

Reference url

Recent Posts

lenacapavir HIV PrEP access
    

Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prevention

💉 How can we ensure equitable access to HIV prevention methods like lenacapavir?

A recent initiative from the Global Fund, supported by key global health organizations, aims to provide affordable access to this new HIV pre-exposure prophylaxis medication.

With a goal to reach 2 million individuals over three years, this coordinated effort seeks to drastically cut HIV infections and align with our commitment to ending AIDS by 2030.

Explore the details of this impactful collaboration and how it could transform HIV prevention.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess

antimicrobial resistance africa
     

Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak

🌍 Are we prepared to tackle the hidden pandemic of antimicrobial resistance (AMR) in Africa?

With AMR rapidly becoming a dominant health crisis, it’s critical to understand its impact on our healthcare systems and most vulnerable populations.

The Africa CDC highlights the urgent need for substantial investment and coordinated responses to combat this escalating threat, alongside the ongoing Mpox outbreak.

Discover the pressing challenges and potential solutions in our latest article.

#SyenzaNews #GlobalHealth #HealthcareInnovation #AntimicrobialResistance #PublicHealth

BioSapien cancer drug delivery
    

BioSapien Innovative Cancer Drug Delivery Solutions

🌟 How is innovation in drug delivery shaping the future of cancer treatment? 🌟

Discover how UAE-based BioSapien is transforming the healthcare landscape with the MediChip™ platform, securing $5.5 million in pre-Series A funding to enhance cancer care.

This innovative solution promises to minimise side effects and improve treatment outcomes for patients, fully embracing the potential of biotechnology in the fight against cancer.

Read more about BioSapien’s journey and its impact on global health!

#SyenzaNews #biotechnology #oncology #innovation #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.